Viewing 0 reply threads
  • Author
    • #391253

      Endo International plc (nasdaq: endp) today announced that one of its operating companies, endo pharmaceuticals inc., is voluntarily recalling two lots of robaxin® (methocarbamol tablets, usp) 750mg Tablets 100 Count Bottle pack to the consumer level. The products have been found to have incorrect daily dosing information on the label due to a labeling error which misstates the daily dose as “two to four tablets four times daily” rather than the correct dosage of “two tablets three times daily.” (see picture below for location of incorrect text).

      Read More…

      This notice provided by

Viewing 0 reply threads
  • You must be logged in to reply to this topic.